Market

Patents from Australia and Eurasia correspond to the NCEs for the treatment of disorders associated with neurodegene-rative…

Seeks stakeholders' suggestions/comments within three weeks

To sell and distribute Cipher’s isotretinoin capsules in Brazil

Cipla Europe (Cipla) and BioQuiddity have entered into a commercial collaboration, covering the territory of the European Union…

To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies

The facility will manufacture oral solids, injectables and topicals

Orders based on expert committee report

Forges first agreement with Desano, Cipla, Mylan, Micro Labs and extends collaborations with Aurobindo, Laurus Labs and Emcure

Approval follows the inspection of both facilities last year

Abbott to get 21 per cent of a newly formed publicly traded company consisting of its developed markets pharma business and…

For middle-income countries the situation is worse, with some countries paying over 12 times more than the lowest known price

Self-owned brands, especially in anti-infectives, lifestyle diseases, dermatology and neurology, to get a major boost

The US Food and Drug Administration has approved Zydelig (idelalisib) to treat patients with three types of blood cancers

Consolidated net profit increases by 43.65 per cent

To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies

The Mumbai market grew the highest at 24.3 per cent followed by Vidarbha at 21.3 per cent

It will be held in Mumbai from October 16-18, 2014; the theme for the event will be ‘The Future of Indian Healthcare: Patients,…